Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben Hansen

Showing results (241-250 of 761) with videos related to

Pageof 77
Sort By:
The Journal of Nutrition|September 16, 2016
Plasma Alkylresorcinols Reflect Gluten Intake and Distinguish between Gluten-Rich and Gluten-Poor Diets in a Population at Risk of Metabolic SyndromeMads V Lind, Mia L Madsen, Jüri J Rumessen, et al.
Plos One|August 27, 2014
A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetesMalene Hornbak, Kristine Højgaard Allin, Majken Linnemann Jensen, et al.
Scientific Reports|January 23, 2020
Describing the fecal metabolome in cryogenically collected samples from healthy participantsKajetan Trošt, Linda Ahonen, Tommi Suvitaival, et al.
Frontiers in Genetics|April 24, 2023
Identifying the genetic causes of phenotypically diagnosed Pakistani mucopolysaccharidoses patients by whole genome sequencingRutaba Gul, Sabika Firasat, Mikkel Schubert, et al.
Frontiers in Genetics|September 29, 2023
Identification of genetic variants associated with a wide spectrum of phenotypes clinically diagnosed as Sanfilippo and Morquio syndromes using whole genome sequencingRutaba Gul, Sabika Firasat, Mikkel Schubert, et al.
Cell Reports. Medicine|November 18, 2020
GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case ReportEva W Iepsen, Christian T Have, Simon Veedfald, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2015
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese WomenEva W Iepsen, Julie R Lundgren, Bolette Hartmann, et al.
Plos One|June 16, 2011
Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult DanesDorthe S Bille, Karina Banasik, Johanne M Justesen, et al.
Plos One|September 14, 2011
Studies of metabolic phenotypic correlates of 15 obesity associated gene variantsCamilla Helene Sandholt, Marie Aare Vestmar, Dorthe Sadowa Bille, et al.
Diabetologia|April 16, 2020
Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort studyTheresia M Schnurr, Hermina Jakupović, Germán D Carrasquilla, et al.
Pageof 77

Showing results (241-250 of 761) with videos related to

Sort By:
Pageof 77
The Journal of Nutrition|September 16, 2016
Plasma Alkylresorcinols Reflect Gluten Intake and Distinguish between Gluten-Rich and Gluten-Poor Diets in a Population at Risk of Metabolic SyndromeMads V Lind, Mia L Madsen, Jüri J Rumessen, et al.
Plos One|August 27, 2014
A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetesMalene Hornbak, Kristine Højgaard Allin, Majken Linnemann Jensen, et al.
Scientific Reports|January 23, 2020
Describing the fecal metabolome in cryogenically collected samples from healthy participantsKajetan Trošt, Linda Ahonen, Tommi Suvitaival, et al.
Frontiers in Genetics|April 24, 2023
Identifying the genetic causes of phenotypically diagnosed Pakistani mucopolysaccharidoses patients by whole genome sequencingRutaba Gul, Sabika Firasat, Mikkel Schubert, et al.
Frontiers in Genetics|September 29, 2023
Identification of genetic variants associated with a wide spectrum of phenotypes clinically diagnosed as Sanfilippo and Morquio syndromes using whole genome sequencingRutaba Gul, Sabika Firasat, Mikkel Schubert, et al.
Cell Reports. Medicine|November 18, 2020
GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case ReportEva W Iepsen, Christian T Have, Simon Veedfald, et al.
The Journal of Clinical Endocrinology and Metabolism|June 5, 2015
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese WomenEva W Iepsen, Julie R Lundgren, Bolette Hartmann, et al.
Plos One|June 16, 2011
Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult DanesDorthe S Bille, Karina Banasik, Johanne M Justesen, et al.
Plos One|September 14, 2011
Studies of metabolic phenotypic correlates of 15 obesity associated gene variantsCamilla Helene Sandholt, Marie Aare Vestmar, Dorthe Sadowa Bille, et al.
Diabetologia|April 16, 2020
Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort studyTheresia M Schnurr, Hermina Jakupović, Germán D Carrasquilla, et al.
Pageof 77